Shares of Cohance Lifesciences fell as much as 10% in early trading on Wednesday, but are recovering from the lows, currently trading 6.4% lower at ₹804.8. The stock is down 28% from its recent 52-week high of ₹1,121, and has declined 25% on a year-to-date basis.
